ETFChannel.com
LLY Description — Lilly (Eli) & Co

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.

Company Name: 
Lilly (Eli) & Co
Website: 
www.lilly.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding LLY: 
125
Total Market Value Held by ETFs: 
$31,220,019,365.52
Total Market Capitalization: 
$306,902,000,000
% of Market Cap. Held by ETFs: 
10.17%
 ETF   LLY Weight   LLY Amount 
 VTI   0.69%   $8,095,612,237         
 VOO   0.82%   $5,575,713,979         
 SPY   0.80%   $2,759,247,946         
 VTV   1.69%   $2,343,891,574         
 IVV   0.80%   $2,211,355,280         
 XLV   5.22%   $1,955,906,821         
 VYM   2.02%   $1,096,249,487         
 VHT   4.63%   $845,374,246         
 IWF   1.25%   $713,741,766         
 QUAL   3.17%   $605,042,097         
List of all 125 ETFs holding LLY »
Quotes delayed 20 minutes

Email EnvelopeFree LLY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.65 out of 4)
54th percentile
(ranked higher than approx. 54% of all stocks covered)

Analysts Forecast:
LLY Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding LLY | Lilly (Eli) & Co | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.